News_News_ProfoundBio (Suzhou) Co., Ltd.



Confirm

Cancel

NEWS

News



News

普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物（ADC）治疗窗口的新型药物连接子技术

普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物（ADC）治疗窗口的新型药物连接子技术

Learn More +

普方生物宣布将在第33届国际分子靶标与癌症治疗大会上展示其旨在扩大抗体偶联药物（ADC）治疗窗口的新型药物连接子技术

ProfoundBio Completed $55+ Million USD Series A Financing

ProfoundBio Completed $55+ Million USD Series A Financing普方生物宣布完成超过5500万美元的A轮融资

Learn More +

ProfoundBio Completed $55+ Million USD Series A Financing普方生物宣布完成超过5500万美元的A轮融资

ProfoundBio Completed $10+ Million USD Series Pre-A Financing

ProfoundBio Completed $10+ Million USD Series Pre-A Financing
ProfoundBio 获险峰旗云投逾千万美元Pre-A轮融资

Learn More +

ProfoundBio Completed $10+ Million USD Series Pre-A Financing
ProfoundBio 获险峰旗云投逾千万美元Pre-A轮融资

Address：Suite 419, Building A4, 218 Xinghu Street, Suzhou Industrial Park, China 215123
E-mail：info@profoundbio.com

E-mail

info@profoundbio.com

TEL

+86-574-88193874

Wechat

Scan to add
Tenglong Wechat